Evidence map›Paper›PMID 23453948›Full record

ArticleThe Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases

Distribution of serotypes and evaluation of antimicrobial susceptibility among human and bovine Streptococcus agalactiae strains isolated in Brazil between 1980 and 2006.

Tatiana Castro Abreu Pinto, Natália Silva Costa, Aline Rosa Vianna Souza, Ligia Guedes da Silva, Ana Beatriz de Almeida Corrêa, Flavio Gimenis Fernandes, Ivi Cristina Menezes Oliveira, Marcos Corrêa de Mattos, Alexandre Soares Rosado, Leslie Claude Benchetrit

Open access · goldAbstract read
In one paragraph

Article in The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 49 citations in OpenAlex.

  1. Trial
  2. Article
  3. Zoonotic Approach toInternational journal of microbiology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Changes in Group BPathogens (Basel, Switzerland) · 2022
    Article
  8. Article
  9. Unusual finding of the human-adapted hypervirulent serotype III/ST17 clone in a historical bovine Group B Streptococcus isolate from Brazil.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2021
    Article
  10. Antimicrobial Resistance among Beta-HemolyticAntibiotics (Basel, Switzerland) · 2021
    Review
  11. Antimicrobial Resistance in Farm Animals in Brazil: An Update Overview.Animals : an open access journal from MDPI · 2020
    Review
  12. Streptococcus agalactiae in pregnant women in Brazil: prevalence, serotypes, and antibiotic resistance.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2019
    Review
  13. Article
  14. Antimicrobial Resistance inMicrobiology spectrum · 2018
    Review
  15. A Perspective on the Potential Zoonotic Role ofFrontiers in microbiology · 2018
    Article
  16. Molecular epidemiology and distribution of serotypes, genotypes, and antibiotic resistance genes of Streptococcus agalactiae clinical isolates from Guelma, Algeria and Marseille, France.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2015
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Tatiana Castro Abreu PintoInstituto de Microbiologia Professor Paulo de Góes, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil. tati.micro@gmail.com
Natália Silva Costa
Aline Rosa Vianna Souza
Ligia Guedes da Silva
Ana Beatriz de Almeida Corrêa
Flavio Gimenis Fernandes
Ivi Cristina Menezes Oliveira
Marcos Corrêa de Mattos
Alexandre Soares Rosado
Leslie Claude Benchetrit
Universidade Federal do Rio de Janeiro · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Streptococcus agalactiae is a common agent of clinical and subclinical bovine mastitis and an important cause of human infections, mainly among pregnant women, neonates and nonpregnant adults with underlying diseases. The present study describes the genetic and phenotypic diversity among 392 S. agalactiae human and bovine strains isolated between 1980 and 2006 in Brazil. The most prevalent serotypes were Ia, II, III and V and all the strains were susceptible to penicillin, vancomycin and levofloxacin. Resistance to clindamycin, chloramphenicol, erythromycin, rifampicin and tetracycline was observed. Among the erythromycin resistant strains, mefA/E, ermA and, mainly, ermB gene were detected, and a shift of prevalence from the macrolide resistance phenotype to the macrolide-lincosamide-streptogramin B resistance phenotype over the years was observed. The 23 macrolide-resistant strains showed 19 different pulsed-field gel electrophoresis profiles. Regarding macrolide resistance, a major concern in S. agalactiae epidemiology, the present study describes an increase in erythromycin resistance from the 80s to the 90s followed by a decrease in the 2000-2006 period. Also, the genetic heterogeneity described points out that erythromycin resistance in Brazil is rather due to horizontal gene transmission than to spreading of specific macrolide-resistant clones.

Indexed as

Genetic VariationAdultAnimalsAnti-Bacterial AgentsBrazilCattleChildDrug Resistance, BacterialElectrophoresis, Gel, Pulsed-FieldFemaleGenotypeHumansMicrobial Sensitivity TestsPhenotypePregnancySerotypingAnti-Bacterial Agents

Identifiers

PMID23453948
PMCPMC9427402
OpenAlexW1988159485

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.